PHARMACEUTICAL PREPARATIONS TREATING GASTRO INTESTINAL

Brand Owner Address Description
OPTIBIOTIC Optibiotix Limited Innovation Centre Innovation Way Heslington, York YO105DG United Kingdom Pharmaceutical preparations for treating gastro-intestinal diseases; dietetic preparations adapted for medical purposes; food supplements and health care preparations in the nature of dietary supplements and nutritional supplements; dietary supplements; nutritional supplements;OPTIC BIOTIC;Chemicals for use in the food industry; bacterial cultures for addition to food products, pro-biotic and pre-biotic bacteria for use in the manufacture of food supplements, dietary supplements, food and beverages; microbes for use in the manufacture of probiotic supplements, prebiotic supplements, nutritional supplements, dietary supplements, food supplements, food and beverages; ingredients for use in the manufacture of foods, namely, probiotic and prebiotic compositions for use as ingredients for food and beverages, namely, probiotic and prebiotic bacteria and probiotic and prebiotic bacterial cultures;Scientific and technological services, namely, scientific research in the field of pharmaceutical and dietic preparations; scientific research and advisory services relating to pharmaceutical and dietetic preparations; scientific screening in connection with bacteria for research purposes; Scientific and product research in the fields of biotechnology, nutritional supplements and food ingredients; design and development for others of new products in the fields of biotechnology, nutritional supplements and food ingredients;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to a microorganism, preferably a bacterial strain, preferably a non-pathogenic strain, preferably a non-invasive strain, preferably a food grade strain, preferably a gram-positive bacterial strain, delivering a trefoil peptide in vivo. Preferably said trefoil peptide is TFF1. The present invention further relates to a method for the delivery of trefoil peptide to the gastro-intestinal tract comprising the administration of such a bacterial strain. The present invention also relates to a pharmaceutical composition comprising a trefoil peptide delivering bacterium as well as methods of treatment of acute gastro-intestinal inflammatory diseases comprising administration of said transformed bacterial strains, particularly for treating acute colitis, including but not limited to acute flare-ups of Crohn's disease and ulcerative colitis in humans, as well as for treating gastro-intestinal disorders of a similar nature in other animal species.